Prudential Financial
LRMR icon

Prudential Financial’s Larimar Therapeutics LRMR Stock Holding History

Prudential Financial’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$392K Buy
128,423
+95,630
+292% +$380K ﹤0.01% 1999
2026
Q1 		$148K Buy
+32,793
New +$131K ﹤0.01% 2186
2025
Q4 		– Sell
-38,091
Closed -$123K – 2342
2025
Q3 		$123K Buy
+38,091
New +$143K ﹤0.01% 2262
2019
Q1 		– Sell
-1,099
Closed -$65K – 2450
2018
Q4 		$65K Buy
+1,099
New +$108K ﹤0.01% 2326

Other funds holding LRMR

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

Prudential Financial's LRMR Position: Q2 2026 in Review

Prudential Financial increased its Larimar Therapeutics (LRMR) stake by 292% in Q2 2026, buying an estimated $380K and bringing the position to 128,423 shares worth $392K. The position accounts for ﹤0.01% of the portfolio, ranked #1999.

Prudential Financial first reported a position in LRMR in Q4 2018 and has held it in 4 quarters since. 163 funds tracked by Wall St. Rank hold LRMR as of Q2 2026.

  • Prudential Financial held 128,423 shares of Larimar Therapeutics worth $392K as of Q2 2026.
  • Prudential Financial bought 95,630 Larimar Therapeutics shares in Q2 2026, an estimated $380K.
  • Larimar Therapeutics made up ﹤0.01% of Prudential Financial's portfolio in Q2 2026, its #1999 holding.
  • Prudential Financial first reported a position in Larimar Therapeutics in Q4 2018 and has held it in 4 quarters since.
  • 163 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.